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Abstract
Background: Engineered inorganic nanoparticles (NPs) are essential components in the development of nanotechnologies. For applications in nanomedicine, particles need to be functionalized to ensure a good dispersibility in
biological fluids. In many cases however, functionalization is not sufficient: the particles become either coated by a
corona of serum proteins or precipitate out of the solvent. We show that by changing the coating of magnetic iron
oxide NPs using poly-l-lysine (PLL) polymer the colloidal stability of the dispersion is improved in aqueous solutions
including water, phosphate buffered saline (PBS), PBS with 10% fetal bovine serum (FBS) and cell culture medium, and
the internalization of the NPs toward living mammalian cells is profoundly affected.
Methods: A multifunctional magnetic NP is designed to perform a near-infrared (NIR)-responsive remote control
photothermal ablation for the treatment of breast cancer. In contrast to the previously reported studies of gold (Au)
magnetic (Fe3O4) core–shell NPs, a Janus-like nanostructure is synthesized with Fe3O4 NPs decorated with Au resulting
in an approximate size of 60 nm mean diameter. The surface of trisoctahedral Au–Fe3O4 NPs was coated with a positively charged polymer, PLL to deliver the NPs inside cells. The PLL–Au–Fe3O4 NPs were characterized by transmission
electron microscopy (TEM), XRD, FT-IR and dynamic light scattering (DLS). The unique properties of both Au surface
plasmon resonance and superparamagnetic moment result in a multimodal platform for use as a nanothermal ablator
and also as a magnetic resonance imaging (MRI) contrast agent, respectively. Taking advantage of the photothermal
therapy, PLL–Au–Fe3O4 NPs were incubated with BT-474 and MDA-MB-231 breast cancer cells, investigated for the
cytotoxicity and intracellular uptake, and remotely triggered by a NIR laser of ~ 808 nm (1 W/cm2 for 10 min).
Results: The PLL coating increased the colloidal stability and robustness of Au–Fe3O4 NPs (PLL–Au–Fe3O4) in biological media including cell culture medium, PBS and PBS with 10% fetal bovine serum. It is revealed that no significant
(< 10%) cytotoxicity was induced by PLL–Au–Fe3O4 NPs itself in BT-474 and MDA-MB-231 cells at concentrations up to
100 μg/ml. Brightfield microscopy, fluorescence microscopy and TEM showed significant uptake of PLL–Au–Fe3O4 NPs
by BT-474 and MDA-MB-231 cells. The cells exhibited 40 and 60% inhibition in BT-474 and MDA-MB-231 cell growth,
respectively following the internalized NPs were triggered by a photothermal laser using 100 μg/ml PLL–Au–Fe3O4 NPs.
The control cells treated with NPs but without laser showed < 10% cell death compared to no laser treatment control
Conclusion: Combined together, the results demonstrate a new polymer gold superparamagnetic nanostructure
that integrates both diagnostics function and photothermal ablation of tumors into a single multimodal nanoplatform exhibiting a significant cancer cell death.
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Background
Assembly of the hyperthermia property of superparamagnetic nanoparticles (NPs) with imaging function into a single nanostructure offers a promising way to dynamically
monitor the progress of the disease and enhance therapeutic
efficacy. Unlike single-component materials, which usually
contain only one unique property of the active ingredient,
the ingredients of multicomponent materials offer the possibility of multimodal application of these functional components thereby increasing versatility of these materials [1,
2]. The development of multicomponent materials as theranostic nanosystems has a potential to establish a new therapeutic mode to combine imaging and hyperthermia, which
can greatly increase the therapeutic efficacy with real-time
monitoring in tissues. Normal tissues and tumors differ
only slightly in relaxation time, and hence, cannot propagate
proper diagnosis signals during magnetic resonance imaging (MRI) [3]. The development of new MRI contrast agents
based on NPs is a fascinating field of research that focuses on
improving MRI techniques for the early detection of disease.
Superparamagnetic NPs such as ferric oxide (Fe3O4) have
been extensively employed as an MRI contrast agent [4–10],
altering the magnetic resonance (MR) signals by reducing
the relaxivity through de-phasing of the transverse magnetization [11, 12]. A gold (Au) shell coating may be useful in this
regard in order to enhance not only the imaging contrasts
for MRI but also the photothermal effect via the plasmonderived optical resonances of gold shells in the visible and
near-infrared region (NIR) [13]. The combination of Aucoated NPs has tremendous potential in improving optical
properties, thermal properties, tunable geometry, and imaging contrasts in MRI. As a bifunctional NP, Au–Fe3O4 can
inherit excellent surface chemistry characteristics, unique
optical properties (attributed to Au) and superparamagnetic characteristics attributed to Fe3O4. First of all, the NPs
offer size controllability, ranging from few to hundreds of
nanometers with different and unique size-dependent properties. Second, the NPs can be easily controlled and manipulated from outside with the help of external magnetic field
being operated from a distance. Third, the NPs can provide
enhanced contrast in medical imaging that can be used to
diagnose the situation efficiently. These characteristics would
enhance and broaden the application of these nanoparticles
for theranostic applications.
While only a few number of Au and magnetic NPs have
been approved for clinical and preclinical trials by the
U.S. Food and Drug Administration (FDA) [14–17], toxicity of both coated and uncoated magnetic NPs remain

a serious concern [18–21]. Both Au and 
Fe3O4 NPs
exhibit toxicity to cells via numerous mechanisms including the disruption of the cell membrane, DNA damage,
induction of oxidative stress, generation of free radicals,
impairment of mitochondrial function and alteration in
cell signaling among others [22–24]. The toxicity may not
be caused by single NP, but rather due to the aggregation
of NPs in biological media and serum [25, 26]. Given the
unstable nature of NP formulation, it is hypothesized that
an optimum dose of a cationic polymer coating onto Au–
Fe3O4 NPs play a role in determining NP configuration
on cellular cytotoxicity as well as direct therapy. Coating the surface of Au–Fe3O4 NPs with suitable polymers
may offer several features: (i) reduced aggregation tendency of the particles; (ii) improved dispersibility; (iii)
enhanced colloidal stability; (iv) protected undesirable
surface oxidation; (iv) surface conjugation for targeting;
(v) decreased cytotoxicity; and (vi) increased intracellular uptake by target cells. A charged polymer coating on
the NP surface enhances the electrosteric stabilization by
attractive and repulsive forces. Poly-l-lysine (PLL) is a
biocompatible polycation that promotes cell adhesion by
the presence of amine (–NH2) groups [27–29]. PLL has
been used to increase blood circulation, improve solubility as well as enhance MRI imaging contrasts of gadolinium imaging chelates [27, 29–32]. Steric stabilization has
proven to be an effective method to improve NP colloidal
stability in ionic media [33]. A uniform coating of F
 e3O4
NPs with polysaccharides leads to a decrease in saturation magnetization as compared to uncoated particles
[34]. This drop in saturation magnetization is undesirable
due to poor signaling in MRI imaging. Therefore, there
is a need for a stable coating on the surface of Au–Fe3O4
NPs to prepare a colloidal dispersion in the biological
medium and attain high MRI imaging contrasts.
In this study, multifunctional Au–Fe3O4 NPs were
designed for medical imaging and hyperthermal treatments of breast cancer cells. To overcome the limitation of colloidal stability and low dispersity of NPs, a
PLL polymeric coating was introduced to the surface of
Au–Fe3O4 as a physical barrier for preventing NP aggregation as well as enhancing their intracellular uptake by
breast cancer cells. Our results showed that the PLL coating on Au–Fe3O4 enhanced it stability in biological fluids
such as water, phosphate buffered saline (PBS), cell culture
medium and PBS containing 10% fetal bovine serum (FBS).
PLL coated Au–Fe3O4 NPs further enhanced the contrast
of MRI imaging signals, exhibited intracellular uptake
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across the breast cancer cell membrane and decreased the
cancer cell viability following photothermal treatment. The
novelty of this work is to generate a nanometer-thick PLL
layer for the stable dispersion of Au–Fe3O4 NPs in biological fluids that results in excellent optical, magnetic and
therapeutic properties for the cancer treatment.

Methods
Synthesis of Au–Fe3O4 NPs

The Au–Fe3O4 NPs were synthesized by a one-pot synthesis technique based on the method that has been
published by Pariti et al. [35]. Briefly, the NPs were synthesized by injecting 2.5 mM of Fe(CO)5, 0.25 mM of
HAuCl4, 2.5 mM oleic acid, and 2.5 mM of oleylamine
into 5 ml of Triton® X-100 at 85 °C. The reaction was
conducted for 10 min in a three-neck round bottom flask
equipped with a magnetic stir bar and air condenser. The
temperature was increased to 300 °C. The product was a
black precipitate that was isolated from the reaction mixture by magnetic filtration, followed by ultrasonication,
centrifugation, and washing to remove excess T
 riton®
X-100 and any unreacted precursors. The powder collected at the bottom of the centrifuge tube was dried in
air. The preparation of Au–Fe3O4 NPs was confirmed by
XRD analysis using a D/max–2400 diffractometer and
CuK radiation (λ = 0.1541 nm).
Polymer coating on Au–Fe3O4 NPs

To coat the NP surface with PLL, 660 µl of 0.1% ( wv )
PLL (Sigma Aldrich, MW: 150,000–300,000) was added
to 25 mg of Au-Fe3O4 NPs and incubated for 24 h at
room temperature (~ 22°C) under continuous shaking.
Unbound PLL was removed by centrifuging at 5000×g
for 30 min that was repeated twice and measured using
the trypan blue assay, spectrophotometry, and a standard
curve (Additional file 1: Figure S1a) [36]. The concentration of Au–Fe3O4 NPs was determined using a standard
curve of the NP absorption at 710 nm peak (Additional
file 1: Figure S1b). The mass ratio of PLL and NPs were
calculated. The presence of PLL coating was confirmed
by Fourier Transform Infrared (FT-IR) spectroscopy.
The FT-IR spectrometer (Perkin-Elmer) was equipped
with an electronic temperature control (ETC) EverGlo IR
Source and a deuterated triglycine sulfate (DTGS) detector. FT-IR analysis was carried out for uncoated and PLL
coated Au–Fe3O4 NPs by mixing with potassium bromide
(KBr) and a pellet method, after a baseline correction
being made with dried KBr, to confirm the compatibility.
The pellet was prepared to a pressure of about 5 × 106 Pa,
in an evacuated chamber, to produce a clear transparent
disc of diameter 2 cm and thickness of 0.2 cm. The spectra were recorded at room temperature (~ 25°C) from
4000 to 400 cm−1.
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Nanoparticle characterization

To measure the dmean of Au–Fe3O4 and PLL–Au–Fe3O4
NPs, transmission electron microscope (TEM) images
were obtained using a Tecnai F20 at an accelerating voltage of 120 kV. A drop of 10 μl of each NP sample in water
was air-dried on carbon-coated copper grids (Ted Pella).
Images were recorded and analyzed using ImageJ (version
1.45S, NIH, USA) to calculate dmean for at least 20 particles. The size distribution of Au–Fe3O4 and PLL–Au–
Fe3O4 NPs was determined by dynamic light scattering
(DLS). The zeta potential was measured via laser Doppler
anemometry using a Zetasizer Nano ZS (Malvern Instruments). Samples were prepared in water, PBS, RPMI 1640
cell culture medium and PBS with 10% FBS. Measurements were performed in triplicates and shown as the
mean ± standard deviation (S.D.). The X-ray diffraction
(XRD) patterns were performed by a Philips X-Pert X-ray
powder diffractometer with CuKα (1.5418 Å) radiation
from 5 to 90°. The UV–Vis absorption spectra of Au–
Fe3O4 and PLL–Au–Fe3O4 NPs were measured using a
Bio-Tek microplate reader (BioTek Synergy 2) between
400 and 900 nm. Fourier transform infrared (FT-IR)
spectroscopy of Au–Fe3O4 and PLL–Au–Fe3O4 NPs was
carried out using a Perkin Elmer Spectrum GX spectrophotometer. Thermal gravimetric analysis (TGA) was
performed using a Q50 thermal gravimetric analyzer (TA
instruments). The samples were heated from 25 to 1000 °C
at a heating rate of 10 °C/min under N2 flow. Results are
expressed in weight percent as a function of temperature.
Spin–spin magnetic relaxation (T2 ms) studies of PLL–Au–
Fe3O4 NPs

To measure the relaxation variables in MRI, Au–Fe3O4 NPs
coated with PLL (PLL–Au–Fe3O4) were prepared in water
at 100 μg/ml concentration. All measurements were conducted at 37 °C using a Bruker’s magnetic relaxometer mq20
(0.47 T, B = 20 MHz) for the spin–spin magnetic relaxation
time (T2) experiments. The specimens were dispersed in
PBS and PBS containing 10% FBS at different Au–Fe3O4
and PLL–Au–Fe3O4 NP concentrations (1, 10 and 100 μg/
ml). The proton spin–spin magnetic relaxation time, T2 was
measured as a function of the NP concentration.
Cytotoxicity of PLL–Au–Fe3O4 NPs in Breast Cancer Cells

BT-474 and MDA-MB-231 breast cancer cells (ATCC)
were cultured at 37 °C and 5% CO2 in Hybri-Care (ATCC)
and RPMI 1640 (Life Technologies), respectively supplemented with 10% FBS (Corning) and 1% (100 units/ml)
Penicillin–Streptomycin (Gibco). Cells in the exponential
growth phase were seeded in a 96-well plate at an initial
density of 10,000 cells/well and incubated overnight. Different concentrations of PLL–Au–Fe3O4 NPs (0–500 μg/
ml) were added to the cell culture media. After 2 h of
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incubation, the media was removed, and the cells were
washed using PBS followed by re-incubation in cell culture media for additional 72 h. The viable and dead cells
were measured using a live–dead (calcein AM; CAM and
EthD–1) assay (Invitrogen) and calculated according to
the manufacturer’s protocol. The cells without any NP
treatments were used as the control. The percentage cell
death was calculated by the following equation:

% cell death =

FNPs − Fblank
× 100
Fcontrol − Fblank

(1)

where FNPs is the Ethd-1 fluorescence of the cells treated
with PLL–Au–Fe3O4 NPs, Fblank is the Ethd-1 fluorescence of the cell culture medium alone, and Fcontrol is the
Ethd-1 fluorescence of the cells without any NP treatments. The concentration at which cell death was less
than 10% was identified as a non-toxic dose.
Intracellular uptake of PLL–Au–Fe3O4 NPs

Cellular uptake of PLL–Au–Fe3O4 NPs was observed using
a Carl Zeiss Axio observer Z1 research microscope system
with Apotome.2 optical structuring device. BT-474 and
MDA-MB-231 cells were seeded in 8-well chambers containing 10,000 cells/well and grown until 70% confluence.
PLL–Au–Fe3O4 NPs of 100 μg/ml were added to the wells,
incubated for 2 h, and washed using PBS for three times.
Live cells were re-incubated with media and imaged on a
Zeiss microscope using a 63× objective (water) through
phase contrast. The intracellular uptake of PLL–Au–
Fe3O4 NPs by BT-474 and MDA-MB-231 cells were further examined by TEM at a voltage of 80 kV. Briefly, cells
were seeded in T25 flasks at a density of 1 × 106 cells/ml.
After overnight incubation at 37 °C and 5% C
 O2, the cells
were incubated with 100 μg/ml PLL–Au–Fe3O4 NPs. After
incubation for another 24 h, the medium was carefully
removed and cells were washed with PBS for three times
and fixed at 4 °C for 1 h using glutaraldehyde (2.5% in
PBS). Then the cells were further subjected to a sequence
of treatments to obtain sections that were subsequently
mounted on copper grids before TEM measurements.
Photothermal treatment of breast cancer cells using PLL–
Au–Fe3O4 NPs

A series of specimens with different PLL–Au–Fe3O4 NP
concentrations (0, 50, 100, 200, 400 and 800 μg/ml) were
put into quartz cuvettes and irradiated by an 808 nm
laser for 10 min with 1 W/cm2 power density. An in situ
thermocouple thermometer (Cole-Parmer) was used to
record the temperature change. To investigate the in vitro
photothermal ablation of breast cancer cells, BT-474 and
MDA-MB-231 cells were incubated with 100 μg/ml of
PLL–Au–Fe3O4 NPs in cell culture media for 2 h, washed

using PBS (3×) to remove the unbound NPs and re-incubated in the corresponding cell culture media for 72 h. The
cells were exposed to NIR light (808 nm pulse laser of 1 W/
cm2 with a diameter of 6 mm for 10 min) to induce photothermal damage. The following control samples were used:
cell culture medium, cells without any treatment, and the
cells treated with PLL–Au–Fe3O4 NPs without any exposure to lasers. After exposure to the NIR light, cells were
incubated for an additional 72 h at 37 °C. Cell viability was
assessed using CAM and EthD-1 (Invitrogen). To further
confirm the in vitro photothermal ablation of breast cancer cells, cytotoxicity following irradiation was also performed using MTT viability assay (Invitrogen). Briefly,
BT-474 and MDA-MB-231 cells were seeded in a 96-well
plate at a density of 10,000 cells/well. After overnight incubation at 37 °C and 5% C
 O2, cells were incubated with
PLL–Au–Fe3O4 NPs of 0, 50, 100, 200, 400 and 800 μg/
ml for 2 h. The medium was replaced with 100 μl of fresh
medium. A 10 μl MTT of 5 mg/ml in PBS was added to the
medium. Cells were incubated at 37 °C for 4 h for labeling
cells with MTT. All medium was removed from the well
except 25 μl. A 50 μl DMSO was added to each well for
dissolving the insoluble formazan crystals. The absorbance
at 540 nm was recorded using a Bio-Tek microplate reader
(Synergy 2). Mean and standard deviations of two independent experiments were reported for each sample.
Statistical analysis

Each experiment was carried out with three independent experiments of at least triplicate measurements. The
mean differences and standard deviations were evaluated.

Results
Synthesis and characterization of PLL–Au–Fe3O4 NPs

TEM images revealed that Au–Fe3O4 NPs were uniform and averaged ~ 55 ± 8.6 nm in diameter (Fig. 1a).
The thickness of PLL coating on Au–Fe3O4 was estimated to be approximately 9 ± 2.5 nm by analyzing the
TEM images (Fig. 1b and c). Additional file 1: Table S1
shows the amount of PLL coating on Au–Fe3O4. The
hydrodynamic diameter of Au–Fe3O4 NPs in water as
characterized using DLS showed a wide size distribution of Au–Fe3O4 dispersions with more than one particle populations and a high polydispersity index (PDI) of
0.856 ± 0.07 (Additional file 1: Figure S2a). The differences in size between TEM and DLS techniques could
be explained by NP agglomeration and the presence of
small aggregates. The PLL coating decreased the PDI of
Au–Fe3O4 NPs from 0.856 to 0.539 ± 0.03 (Table 1). The
hydrodynamic diameters of NPs after PLL coating eliminated the large and small particle aggregates in water,
PBS, RPMI 1640 cell culture medium and PBS containing
10% FBS indicating a better colloidal stability (Additional
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Fig. 1 TEM images showing Au–Fe3O4 NPs a without, and b, c with PLL coating. Scale bar = 50 nm in a, b, and 20 nm in c. The dark black circles
indicate Au and the shaded hexagons represent Fe3O4. Arrows in c indicate a thin layer of PLL coating

Table 1 Characterization of Au–Fe3O4 before and after PLL coating
Samples

Au–Fe3O4
PLL–Au–Fe3O4

ζ-potential (mV) in various biological medium
PDI

Water

0.856 ± 0.07

− 7.9 ± 0.8

0.539 ± 0.03

35 ± 10

file 1: Figure S2b). The stability of PLL–Au–Fe3O4 NPs
was further proved using a time-resolved video (Additional file 2: Movie S1). As you can see from this video
that Au–Fe3O4 NPs without any coating (left-hand side
tube in the video) precipitate down quickly in water while
PLL–Au–Fe3O4 NPs (right-hand side tube) were stably
suspended in the black emulsion.
The Au–Fe3O4 NPs possess a negative surface charge
of − 7.9 ± 0.8 mV and − 12 ± 7 mV in water and PBS,
respectively as determined by zeta potential (Table 1 and
Fig. 2a). The zeta potentials of Au–Fe3O4 NPs increased
in cell culture medium and PBS with 10% FBS indicating
pronounced differences in the particle surface chemistry
caused by different solvent compositions. The PLL coated
Au–Fe3O4 NPs showed a strong positive charge in water
and PBS due to the positive amine groups on the polymer backbone which confirmed the successful grating of
PLL polymer on the surface of NPs (Table 1 and Fig. 2b).
This further confirms that the PLL coating made the NPs
disperse better in aqueous solutions and as a result no
agglomeration on storage. Particles that are surface engineered with amine functional groups like PLL has been
reported to the effective release of encapsulated molecules from endosomal compartments [37].
The crystal structures of Au–Fe3O4 and PLL–Au–
Fe3O4 NPs were recorded by the X-ray diffraction (XRD),

PBS
− 12 ± 7

26 ± 8.5

Cell culture medium

PBS + 10% FBS

− 3.4 ± 5.2

− 4.8 ± 2.6

15.8 ± 9.2

16 ± 6.8

as shown in Fig. 3a. The XRD pattern of Fe3O4 shows
characteristic peaks at (111), (220), (311), (400), (422),
(511) and (440), and (111), (200), (220), (311), (222) peaks
for Au which is in agreement to the controls of F
 e3O4–
PDF # 65–3107 and Au–PDF # 05–0681, respectively.
XRD pattern contains no impurity peak indicating the
high purity of Au and F
 e3O4 samples and perfect phase
transformation. The XRD pattern of PLL–Au–Fe3O4 NPs
has similar diffraction peaks as those of Au–Fe3O4 NPs
with more peak to noise ratio which could be attributed
to PLL polymeric coating.
To confirm the successful synthesis of NPs, UV–Vis
absorption and FT-IR spectra were measured. A complete spectra analysis of Au–Fe3O4 NPs shows a broad
surface plasmon absorption with an absorption maximum at around 710 nm (λmax) (Fig. 3b; dotted line) [38].
The PLL coating showed an absorption shift to lower
wavelengths with an absorption maximum at 640 nm
(Fig. 3b; solid line). This explains the enhanced dispersion
of PLL–Au–Fe3O4 NPs in the aqueous phase by redistributing agglomerated Au–Fe3O4 NPs.
FT-IR spectra were used to study the transformation of Au–Fe3O4 and PLL–Au–Fe3O4 NP compositions
(Fig. 3c). As shown in Fig. 3c, the strong absorption
peak at about 590 cm−1 in the FT-IR of Au–Fe3O4 originates from Fe–O stretching of the F
 e3O4 core. The bare
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PBS

RPMI 1640 cell culture medium
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b

Water

PBS

RPMI 1640 cell culture medium

PBS + 10% FBS
PBS + 10% FBS

Fig. 2 Surface zeta potential of a Au–Fe3O4, and b PLL–Au–Fe3O4 NPs in water, PBS, RPMI 1640 cell culture medium and PBS containing 10% FBS.
Three colored (red, green and blue) lines indicate three replicates from three independent experiments. Multiple peaks in Au–Fe3O4 (a) indicate
their aggregation behavior that disappears after PLL coating (b)

Au–Fe3O4 spectrum contains a peak at 1630 cm−1 due to
water physisorbed on the iron oxide surface and a broad
band around 3400 cm−1 due to surface hydroxyl groups
(Fe–OH). For PLL–Au–Fe3O4 NPs, new and broad
absorption bands were observed in the range of 3340 and
3600 cm−1, which were attributed to amine N–H stretching and O–H stretching, respectively. The peaks at 1647
and 1587 cm−1 attributed to the stretching vibration of
C=O from the PLL coating.
To quantify the amount of PLL on the surface of PLL–
Au–Fe3O4 NPs, TGA was performed (Fig. 3d). The PLL
coating results in a weight loss of 7.4% between 100 and

650 °C when compared with the uncoated particles (Au–
Fe3O4). No change in PLL–Au–Fe3O4 mass was observed
above 850 °C. Combinedly these findings suggest a successful surface functionalization of Au–Fe3O4 NPs by
PLL polymer coating.
Determination of T2 magnetic relaxation of Au–Fe3O4
and PLL–Au–Fe3O4 NPs using magnetic relaxometer

It is important to determine the overall magnetic properties of Au–Fe3O4 and PLL–Au–Fe3O4 NPs for cancer
imaging by MRI technique. It is expected that the synthesize Fe3O4 nanocomposites will be MR active as they are
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b

d

Fig. 3 a XRD patterns; b Absorption spectra (solid line: PLL–Au–Fe3O4 NPs and dotted line: Au–Fe3O4 NPs); c FT-IR characterization and d TGA
curves of Au–Fe3O4 and PLL–Au–Fe3O4 NPs

superparamagnetic in nature. The spin–spin MR times
(T2 ms) were analyzed in order to evaluate the magnetic
properties of Au–Fe3O4 with and without the PLL coating (Additional file 1: Figure S3). Generally, the spin–
spin magnetic relaxation of water protons changes in
the presence of magnetic materials in the solution, such
as synthesized Au–Fe3O4 NPs. This leads to enhance the
magnetic property of the solution. Fe3O4 NPs are generally used for MR contrast agents because of their capacity to shorten the T
 2 relaxation time of their surrounding
protons. As can be clearly seen in Additional file 1: Figure S3, T2 was decreased gradually with the increase in
NP concentration. The T2 relaxation time of PLL–Au–
Fe3O4 NPs was higher than that of Au–Fe3O4 NPs due

to the fact that the polymer coating displaces the water
molecules from the vicinity of the Au–Fe3O4 nanocomposite, leading to an increase in the MR values. However,
at higher concentrations, the MR values are comparable
and the PLL-coated Au–Fe3O4 NPs would be ideal for
cancer imaging due to the higher bioavailability and minimal cytotoxicity. These results indicated that the formulated nanocomposites are superparamagnetic and ideal
for cancer MR imaging.
Cytotoxicity study by PLL–Au– Fe3O4 NPs and its
intracellular uptake

Figure 4a shows the cytotoxicity induced by various
concentrations of PLL–Au–Fe3O4 NPs in BT-474 and
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a

b

c

Fig. 4 a Cytotoxicity of PLL–Au–Fe3O4 NPs in BT-474 and MDA-MB-231 cells using live-dead assay at increasing NP concentration; Cellular uptake of
PLL–Au–Fe3O4 NPs in b BT-474 and c MDA-MB-231 cells. Arrows indicate the NPs inside cells. Cells without any NP treatment (control) did not show
the black NP dots inside cells. Scale bar = 10 μm
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MDA-MB-231 cells is dose-dependent. PLL–Au–Fe3O4
NPs did not show much cytotoxicity (≤ 20% cell death)
at a concentration ≤ 100 μg/ml, and hence the concentration was chosen for subsequent studies. To investigate
the intracellular uptake of the NPs, phase contrast images
were used. It can be seen from Fig. 4b and c that the
PLL–Au–Fe3O4 NPs (black spots as indicated by arrows)
entered in the cytoplasm of BT-474 and MDA-MB-231
cells. No black clusters were found in control cells without any NPs indicating the internalization of NPs by the
cells. No morphological changes in cellular physiology
have been observed when compared to control cells demonstrating negligible cytotoxicity by PLL–Au–Fe3O4 NPs.
The uptake of PLL–Au–Fe3O4 NPs was further evaluated
by TEM imaging (Additional file 1: Figure S4). Clearly,
cells treated with NPs show a remarkable distribution
inside endoplasmic vesicles of the cells.
Photothermal effects by PLL–Au–Fe3O4

In order to investigate, the potential of PLL–Au–Fe3O4
as nanothermal ablators, suspensions of the NPs in PBS
were irradiated using 808 nm light emitted by a laser.
The photothermal behavior of PLL–Au–Fe3O4 NPs was
investigated by a temperature change versus the NP concentration (Fig. 5). Clearly, the NPs were able to induce a
temperature enhancement in a concentration-dependent
manner. The temperature of the NP suspension reached
50 °C at the PLL–Au–Fe3O4 NP concentration of 800 μg/
ml. Laser irradiation of PBS negative control without NPs
did not show any temperature increase under the same
conditions. The results indicate that the synthesized
PLL–Au–Fe3O4 NPs were able to transform NIR laser
into heat under laser irradiation. For laser treatment,

Fig. 5 Temperature change of a PBS solution containing PLL–Au–
Fe3O4 NPs under an 808 nm laser irradiation as a function of different
NP concentrations
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BT-474 and MDA-MB-231 cells were first incubated
with PLL–Au–Fe3O4 NPs for 2 h followed by a wash
process to remove un-internalized NPs, laser irradiation for 10 min and then for additional 72 h incubation
period. In the control groups (cells + laser irradiation in
absence of NPs), no significant cell death was observed.
The cells treated with 100 μg/ml of PLL–Au–Fe3O4 NPs
but without laser illumination reached 90 ± 4.7% of cell
survival rate compared to those treated with PBS control. In contrast, the combination of PLL–Au–Fe3O4 NPs
and laser treated cells underwent photothermal destruction as shown by both phase contrast and cell viability
(green live cells) and dead cell (red stain) staining (Fig. 6).
The groups for PLL–Au–Fe3O4 NPs + 10 min exposure
to laser illumination at 1 W/cm2 showed the inhibition
in cell growth by 49 ± 12% in BT-474 cells (Fig. 7; filled
circle) and 60 ± 10% in MDA-MB-231 cells (Fig. 7; open
circle) suggesting significant therapeutic effects following the photothermal treatment. Cells without any treatment, with laser treatment alone and with NP groups
showed ≤ 5% inhibition in cell growth. The cytocompatibility of PLL–Au–Fe3O4 NPs was further assessed by
MTT cell viability assay (Additional file 1: Figure S5). The
quantitative analysis further reveals that the percentage
of cell viability decreased to 63.5 ± 5.5% and 31.6 ± 3.2%
in BT-474 and MDA-MB-231 cells, respectively at concentrations ≥ 10 μg/ml of NPs following laser irradiation.

Discussion
A dumbbell-shaped Au–Fe3O4 superparamagnetic NPs is
synthesized that is similar in morphology to multifaceted
Janus particles [39, 40]. The structure (Au–decorated
Fe3O4) is chosen to provide added advantages of both Au
and Fe3O4 functionalities for the full utilization of their
potential. Several Au dots on the F
 e3O4 host ensures that
there is a maximum number of spots for molecular recognition since Au-terminal acts as anchors for targeting
agents. Perhaps the most challenging aspect of applying
Au–Fe3O4 NPs involves the colloidal stability and shelflife, surface functionalization, cellular internalization, and
biocompatibility. Designing a properly grafted surface is
therefore of paramount importance. Dextran [41], PEG
[42], and silica coating [43] have been used extensively,
however, each method has its benefits and drawbacks
and requires trade-offs and optimizations. For example,
although silica coatings can provide colloidal stability,
it may also retard R
 2 relaxation in MRI imaging, as well
dampen the superparamagnetic moment which reduces
hyperthermia efficiency. Reduction in the superparamagnetic moment also leads to the necessity for increased
dosage of the magnetic NPs. In that regards, the Januslike particle with larger Fe3O4 anchored with several Au
dots serves the multifaceted purpose of retaining high
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BT-474:
Laser; no NPs
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Laser + 100 g/ml
PLL Au Fe3 O4

MDA-MB-231:
Laser; no NPs

Laser + 100 g/ml
PLL Au Fe3 O4

Phase
contrast

Calcein
AM

EthD-1

50 m

10 m

Fig. 6 Phase contrast (row 1) and fluorescence (rows 2 and 3) images of BT-474 and MDA-MB-231 cells treated with 2 h incubation of PLL–Au–
Fe3O4 followed by 10 min laser irradiation and 72 h of incubation in the medium. Uninternalized NPs were washed with PBS before the imaging.
Green fluorescence represents live cells as stained with calcein AM, while the red fluorescence represents dead cells as stained with EthD-1. Scale
bars are shown on images

Fig. 7 Quantitative assay of BT-474 (solid line; filled circle) and
MDA-MB-231 (dotted line; open circle) cell growth inhibition
following photothermal therapy in presence of PBS + laser and
100 μg/ml of PLL–Au–Fe3O4 NPs. The data represent the average of
three independent experiments

superparamagnetic moment over larger size [35] as well
as optimizing SPR and photothermal effect of Au. Here,
we report a simple and versatile method to adsorb PLL
on bare Au–Fe3O4 dispersed in aqueous solutions. The
polycationic PLL backbone ensures tight coulomb attachment onto anionic surfaces of Au endowing the NP surface with a robust coverage.
This approach can be generalized to many anionic surfaces onto which cationic polymers can adhere tightly,
such as glass or silica. The results are comparable with
previous studies on Au nanoshells where polymers (i.e.,
polyethylene imine; PEI) have been used as an intermediate separating layer during the fabrication of Au–Fe3O4
where the polymer layer prevents the migration of Au
shell into the magnetic core by connecting between the
core and shell structure [44, 45]. In contrast, we show an
outer layer of PLL on the surface of Au–Fe3O4 that attribute to the columbic interactions between the Au surface
and aliphatic monoamines that is clearly responsible for
the observed stability of Au–Fe3O4 against aggregation
in PBS. The TEM images showed the presence of a layer
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of PLL of approximately 9 nm thickness. The PLL coating
improved the interaction of negatively charged Au–Fe3O4
at the cellular level by the resulting surface charge as confirmed by the zeta potential data.
The next step of PLL–Au–Fe3O4 involves cell culture
experiments that suggest the overall intracellular uptake
of the NPs at a non-toxic dose in breast cancer cells. The
live/dead assay indicates that PLL–Au–Fe3O4 NPs are
not cytotoxic in breast cancer cells at concentrations
≤ 100 μg/ml (Fig. 5). When compared to other cell viability data of polymer-coated NPs, our results are comparable to the literature data showing 20% reduction in
cell viability using similar NP concentrations [45, 46].
Furthermore, the results from the phase contrast imaging microscopy demonstrated the effective internalization of the NPs presumably due to the combination of
electrostatic interaction with the negatively charged glycocalyx on the cell membrane [47, 48] and the receptormediated endocytosis via EGCG [49–53]. The results
are in agreement with the previous finding where Au
NPs functionalized with methoxy-PEG-thiol were internalized by MDA-MB-231 cells via endocytosis [54, 55].
Importantly, the observed uptake of PLL–Au–Fe3O4
NPs by breast cancer cells associated with low toxicity suggest a potential theranostic use of these Au NPs.
It is worth noting that PLL–Au–Fe3O4 had higher levels
of uptake in MDA-MB-231 cells than BT-474 cells. The
differences in cell surface protein expressions and proteoglycans may attribute to the differential uptake of NPs
inside the cells [56–58]. Importantly, the higher observed
uptake of PLL–Au–Fe3O4 in MDA-MB-231 than BT-474
cells was associated with pronounced toxicity (Fig. 5 and
6) suggesting a potential theranostic use of these gold
nanoparticles.
Multiple studies have demonstrated the heating effect
of Au shell NPs. Thermal ablation using PEG-coated Au
nanoshells with silica cores have been reported to induce
photothermal morbidity in SK-BR-3 breast cancer cells
[59]. The treated cells revealed lost in cell membrane
integrity and cell death that was not observed in the controls with laser irradiation or gold nanoshells alone [59].
Photothermal destruction was effective in reducing colon
tumors in mice with a mean survival life of 90 days after
the treatment [60]. We found that at 100 μg/ml of PLL–
Au–Fe3O4 and 10 min laser exposure, a ΔT of 15 ± 7.6 °C
was achieved. The current study reveals the effectiveness
of using PLL–Au–Fe3O4 as a potent MRI-visible photosensitizer during the laser irradiation of cancer cells
[45, 61, 62]. The noticeable combination of properties of
PLL–Au–Fe3O4 with the local application of NIR laser
irradiation offers a promising approach for the photothermal ablation therapy of breast cancer cells following
internalization inside cells.
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Conclusions
A multifunctional NP was constructed using the PLL
polymer coating on Au–Fe3O4 with a mean diameter
of ~ 60 nm that are less prone to aggregation and thus
suitable for a wide range of biological applications.
PLL–Au–Fe3O4 NPs showed good colloidal stability,
NIR light absorption property, magnetic relaxivity and
cytocompatibility. Upon exposure to a NIR light, the
SPR of Au increased their temperature inside the cells.
The PLL–Au–Fe3O4 NPs were also demonstrated the
importance of having a surface of the polymer layer
that enhanced MRI contrast. As an integrated all-inone NP platform, the polymeric theranostic agent was
shown for intracellular uptake and hyperthermal treatments of breast cancer cells for further translational
therapeutic applications.

Additional files
Additional file 1: Figure S1. (a) PLL trypan blue standard curve; and
(b) Au–Fe3O4 concentration measurement standard line. Figure S2.
Hydrodynamic diameters of (a) Au–Fe3O4 NPs and (b) PLL coated Au–
Fe3O4 NPs in water as measured by dynamic light scattering (DLS). Three
color codes indicate three independent DLS measurements. Figure S3.
Magnetic relaxation (MR) characterization of (A and C) Au–Fe3O4 and
(Band D) PLL–Au–Fe3O4 NPs. A) Spin-spin MR (T2 ms) of bare Au–Fe3O4
NPs was found to be 190 ms, whereas, it was B) 280 ms for PLL–Au–Fe3O4
NPs at a given concentration of 10 μg/mL. This change in T2 MR value is
the indicative of effective PLL coatings. Concentration dependent (1–100
μg/mL) T2 values were obtained in PBS (pH 7.2) and in 10% FBS for C)
Au–Fe3O4 and D) PLL–Au–Fe3O4 NPs. These results indicated that with
increase in concentration, the MR properties of these NPs increase and
were found to be stable in physiological pH and in sera. Figure S4. The
PLL–Au–Fe3O4 NPs uptake by (a) BT-474 and (b) MDA-MB-231 cells after
24 h incubation. Red circles indicate the endosomal vesicles that clearly
retain the NPs as appeared in dark black spots. Figure S5. MTT cell viability assay of BT-474 (filled circle, solid line) and MDA-MB-231 (open circle,
dotted line) cell viability after treatment with PLL–Au–Fe3O4 NPs under a
650 nm laser irradiation for 10 min. Table S1. The percentage encapsulation efficiency of PLL on Au–Fe3O4 NPs.
Additional file 2: Movie S1. This video shows Au–Fe3O4 (left) and PLL–
Au–Fe3O4 NPs (right) where PLL coating prevents NP settle down in water
and therefore black PLL–Au–Fe3O4 NPs’ colloidal suspension is observed.
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